Literature DB >> 11933202

The identification of eight novel glucocerebrosidase (GBA) mutations in patients with Gaucher disease.

E Orvisky1, J K Park, A Parker, J M Walker, B M Martin, B K Stubblefield, E Uyama, N Tayebi, E Sidransky.   

Abstract

Mutations in the gene encoding for the lysosomal enzyme glucocerebrosidase (GBA) result in Gaucher disease. In this study, seven novel missense mutations in the glucocerebrosidase gene (A136E, H162P, K198E, Y205C, F251L, Q350X and I402F) and a splice site mutation (IVS10+2T-->A) were identified by direct sequencing of three amplified segments of the glucocerebrosidase gene. Five of the novel mutations were found in patients with neuronopathic forms of Gaucher disease, two of which, K198E and F251L, appear to be associated with type 2 Gaucher disease. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11933202     DOI: 10.1002/humu.9024

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  5 in total

1.  Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model.

Authors:  Nupur Dasgupta; You-Hai Xu; Ronghua Li; Yanyan Peng; Manoj K Pandey; Stuart L Tinch; Benjamin Liou; Venette Inskeep; Wujuan Zhang; Kenneth D R Setchell; Mehdi Keddache; Gregory A Grabowski; Ying Sun
Journal:  Hum Mol Genet       Date:  2015-09-29       Impact factor: 6.150

2.  Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease.

Authors:  Nahid Tayebi; Barbara K Stubblefield; Joseph K Park; Eduard Orvisky; Jamie M Walker; Mary E LaMarca; Ellen Sidransky
Journal:  Am J Hum Genet       Date:  2003-02-13       Impact factor: 11.025

3.  Prevalence of GBA p.K198E mutation in Colombian and Hispanic populations.

Authors:  Philip W Tipton; Alexandra I Soto-Beasley; Ronald L Walton; Silvia Soler-Rangel; Óscar Romero-Osorio; Cindy Díaz; Claudia Lucía Moreno-López; Owen A Ross; Zbigniew K Wszolek; Catalina Cerquera-Cleves
Journal:  Parkinsonism Relat Disord       Date:  2020-03-12       Impact factor: 4.891

4.  The distribution and risk effect of GBA variants in a large cohort of PD patients from Colombia and Peru.

Authors:  Carlos Velez-Pardo; Oswaldo Lorenzo-Betancor; Marlene Jimenez-Del-Rio; Sonia Moreno; Francisco Lopera; Mario Cornejo-Olivas; Luis Torres; Miguel Inca-Martinez; Pilar Mazzetti; Carlos Cosentino; Dora Yearout; Sarah M Waldherr; Cyrus P Zabetian; Ignacio F Mata
Journal:  Parkinsonism Relat Disord       Date:  2019-02-04       Impact factor: 4.891

5.  Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.

Authors:  Ying Sun; Benjamin Liou; Huimin Ran; Matthew R Skelton; Michael T Williams; Charles V Vorhees; Kazuyuki Kitatani; Yusuf A Hannun; David P Witte; You-Hai Xu; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2010-01-04       Impact factor: 6.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.